BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 24574441)

  • 1. Transcatheter aortic valve implantation reduces grade of concomitant mitral and tricuspid valve regurgitation and pulmonary hypertension.
    Wilbring M; Tugtekin SM; Ritzmann M; Arzt S; Schmidt T; Matschke K; Kappert U; Alexiou K
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):818-24. PubMed ID: 24574441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricuspid but not Mitral Regurgitation Determines Mortality After TAVI in Patients With Nonsevere Mitral Regurgitation.
    Amat-Santos IJ; Castrodeza J; Nombela-Franco L; Muñoz-García AJ; Gutiérrez-Ibanes E; de la Torre Hernández JM; Córdoba-Soriano JG; Jiménez-Quevedo P; Hernández-García JM; González-Mansilla A; Ruano J; Tobar J; Del Trigo M; Vera S; Puri R; Hernández-Luis C; Carrasco-Moraleja M; Gómez I; Rodés-Cabau J; San Román JA
    Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):357-364. PubMed ID: 29079280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation.
    Hutter A; Bleiziffer S; Richter V; Opitz A; Hettich I; Mazzitelli D; Ruge H; Lange R
    Ann Thorac Surg; 2013 Jan; 95(1):77-84. PubMed ID: 23063197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative risk factors of medium-term mitral valve repair outcome.
    Wang J; Han J; Li Y; Xu C; Jiao Y; Yang B; Meng X; Bolling SF
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):946-54. PubMed ID: 25217622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitral-Tricuspid Regurgitation Change After Transcatheter Aortic Valve Implantation and Its Effect on Mortality and Hospitalization.
    Adıgözelzade S; Asil S; Keskin ÖF; Erdoğan S; Görmel S; Yaşar S; Fırtına S; Yıldırım E; Buğan B; Çelik M; Barçın C; Yüksel UÇ
    Turk Kardiyol Dern Ars; 2024 Jan; 52(1):10-17. PubMed ID: 38221830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitral regurgitation prior to transcatheter aortic valve implantation influences survival but not symptoms.
    Boerlage-van Dijk K; Wiegerinck EM; Takama T; Koch KT; Vis MM; de Mol BA; Piek JJ; Bouma BJ; Baan J
    Int J Cardiol; 2016 Feb; 204():95-100. PubMed ID: 26655549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement.
    Barbanti M; Binder RK; Dvir D; Tan J; Freeman M; Thompson CR; Cheung A; Wood DA; Leipsic J; Webb JG
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):677-84. PubMed ID: 24740834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of tricuspid regurgitation and new pacemaker implantation in patients undergoing transcatheter aortic valve implantation.
    Schewel D; Schewel J; Schlüter M; Kreidel F; Schmidt T; Schmoeckel M; Elsässer A; Kuck KH; Frerker C
    Int J Cardiol; 2018 Jun; 261():37-41. PubMed ID: 29572082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
    O'Sullivan CJ; Stortecky S; Bütikofer A; Heg D; Zanchin T; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Blöchlinger S; Carrel T; Meier B; Zbinden S; Wenaweser P; Windecker S
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001895. PubMed ID: 25657315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic predictors of adverse short-term outcomes after heart surgery in patients with mitral regurgitation and pulmonary hypertension.
    Corciova FC; Corciova C; Georgescu CA; Enache M; Anghel D; Bartos O; Tinica G
    Heart Surg Forum; 2012 Jun; 15(3):E127-32. PubMed ID: 22698598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR: An Analysis From the TriValve and TRAMI Registries.
    Mehr M; Karam N; Taramasso M; Ouarrak T; Schneider S; Lurz P; von Bardeleben RS; Fam N; Pozzoli A; Lubos E; Boekstegers P; Schillinger W; Plicht B; Eggebrecht H; Baldus S; Senges J; Maisano F; Hausleiter J;
    JACC Cardiovasc Interv; 2020 Mar; 13(5):543-550. PubMed ID: 31954679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of preoperative mitral valve regurgitation on outcomes after transcatheter aortic valve implantation.
    D'Onofrio A; Gasparetto V; Napodano M; Bianco R; Tarantini G; Renier V; Isabella G; Gerosa G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1271-6; discussion 1276-7. PubMed ID: 22219481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of moderate secondary mitral regurgitation at the time of aortic valve surgery.
    Coutinho GF; Correia PM; Pancas R; Antunes MJ
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):32-40. PubMed ID: 23345178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High-Risk Patients with Aortic Stenosis.
    Perl L; Vaturi M; Assali A; Sagie A; Weissler-Snir A; Codner P; Orvin K; Vaknin-Assa H; Shapira Y; Kornowski R
    J Heart Valve Dis; 2015 Jul; 24(4):439-44. PubMed ID: 26897813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of mitral and tricuspid regurgitation in patients with severe aortic stenosis.
    Zilberszac R; Gleiss A; Binder T; Laufer G; Grimm M; Gabriel H; Maurer G; Rosenhek R
    Eur Heart J Cardiovasc Imaging; 2018 Sep; 19(9):985-992. PubMed ID: 29506023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The failing right heart: implications and evolution in high-risk patients undergoing transcatheter aortic valve implantation.
    Testa L; Latib A; De Marco F; De Carlo M; Fiorina C; Barbanti M; Montone RA; Agnifili M; Petronio AS; Ettori F; Klugmann S; Tamburino C; Brambilla N; Colombo A; Bedogni F
    EuroIntervention; 2016 Dec; 12(12):1542-1549. PubMed ID: 27998847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricuspid regurgitation in patients with severe mitral regurgitation and normal left ventricular ejection fraction: risk factors and prognostic implications in a cohort of 895 patients.
    Varadarajan P; Pai RG
    J Heart Valve Dis; 2010 Jul; 19(4):412-9. PubMed ID: 20845886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tricuspid regurgitation velocity and probability of pulmonary hypertension in patients undergoing transcatheter aortic valve implantation.
    Kleczynski P; Dziewierz A; Wiktorowicz A; Bagienski M; Rzeszutko L; Sorysz D; Trebacz J; Sobczynski R; Tomala M; Dudek D
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1931-1938. PubMed ID: 28668978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricuspid Valve Repair for the Poor Right Ventricle: Tricuspid Valve Repair in Patients with Mild-to-Moderate Tricuspid Regurgitation Undergoing Mitral Valve Repair Improves In-Hospital Outcome.
    Zientara A; Genoni M; Graves K; Odavic D; Löblein H; Häussler A; Dzemali O
    Thorac Cardiovasc Surg; 2017 Dec; 65(8):612-616. PubMed ID: 25629457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.